Li study confirms his earlier finding that associates long-term tamoxifen use with more than four-fold increased risk of aggressive, difficult to treat type of contralateral breast cancer
National Minority Cancer Awareness Week Five Sites in Washington and Oregon Hope to Recruit More Women To the Study of Tamoxifen and Raloxifene, known as STAR